Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PC | P11498 | 7/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | F3 | P13726 | 4/20 | 0.60 |
| ▸ | CES2 | O00748 | 1/20 | 0.60 |
| ▸ | CES1 | P23141 | 1/20 | 0.60 |
| ▸ | XDH | P47989 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | PRKCG | P05129 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3244839 | 1.00 | PC (0.83) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL13164838 | 1.00 | PC (0.83) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL28280706 | 1.00 | PC (0.83) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL13164859 | 1.00 | PC (0.83) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL15450689 | 1.00 | PC (0.83) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL29785205 | 1.00 | PC (0.83) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL16704685 | 0.95 | PC (0.81) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL16704630 | 0.95 | PC (0.81) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL15445080 | 0.95 | PC (0.81) | PCMAPK1USP2LMNATP53 | |
| SCHEMBL14555897 | 0.94 | PC (0.74) | PCMAPK1USP2LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637474-B2 | Receptor modulators exhibiting neuroprotective and memory enhancing activities | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (HK) | 2014-01-28 | — | — | US | disclosed |
| US-20130012462-A1 | RECEPTOR MODULATORS EXHIBITING NEUROPROTECTIVE AND MEMORY ENHANCING ACTIVITIES | BIOTECHNOLOGY RESEARCH CORPORATION LIMITED (CN) | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012462-A1 | RECEPTOR MODULATORS EXHIBITING NEUROPROTECTIVE AND MEMORY ENHANCING ACTIVITIES | GRIN1, GRIN2A, GRM1 | PC 314/4885MAPK1 507/4885USP2 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.